Skip to main content
. 2020 Mar 12;20:196. doi: 10.1186/s12885-020-6589-x

Fig. 1.

Fig. 1

The Protocol for this clinical trial. The scheme of the Protocol for this clinical trial is shown. VEGFR1 and R2 peptide were injected eight times every week and then six times monthly (a total of 14 times). Vaccination was synchronized with adjuvant TMZ